Serotonin involvement in cocaine sensitization: Clues from studies with cocaine analogs

While the behavioral effects of cocaine are generally ascribed to its ability to inhibit the uptake of dopamine, there is evidence to indicate that some of the other pharmacological properties of cocaine may play a significant role in its actions. Behavioral, biochemical, and electrophysiological data suggest that the potent inhibition of serotonin uptake elicited by cocaine is a mechanism that may contribute to its overall effects in vivo. Cocaethylene is the ethyl ester of benzoylecognine which is formed in vivo during concurrent ingestion of cocaine and ethanol. Cocaethylene is equipotent with cocaine as an inhibitor of dopamine uptake, but less potent as an inhibitor of serotonin uptake. We have compared the effects of acute and chronic cocaine and cocaethylene on rat locomotor activity in an attempt to determine the serotonin component in this behavior. Acute dose‐response studies revealed that at higher doses (20 mg/kg ip) cocaethylene produced less stimulation of locomotor activity than cocaine. Prior exposure to cocaine resulted in an augmented response to a subsequent challenge dose of either cocaine (sensitization) or cocaethylene (cross‐sensitization). However, previous treatment with cocaethylene did not significantly affect the locomotor activity produced by challenges with cocaethylene or cocaine. The involvement of serotonergic systems in the development of cocaine‐induced sensitization is one intriguing possible explanation of these data. Biochemical studies have shown that other cocaine analogs possess even more selectivity for the dopamine uptake site than cocaethylene. In terms of comparative potency as inhibitors of dopamine, serotonin, and norepinephrine uptake, isopropylcocaine (isopropyl ester of benzoylecognine) is more selective than even cocaethylene. A metabolically resistant analog of cocaine, β‐CIT (2β‐carbomethoxy‐3β‐(4‐iodophenyl)tropane), was shown to be extraordinarily long‐acting, stimulating locomotor activity for 10 h following a dose of 0.1 mg/kg ip. Furthermore, β‐CIT was extremely potent, inhibiting dopamine or serotonin uptake in vitro at a concentration 100 times lower than is required for cocaine. Thus, isopropyl or other substitutions at the carbomethoxy position of the cocaine or β‐CIT structures may provide useful tools for the analysis of the serotonin or norepinephrine components in cocaine's actions and as selective probes of central dopamine systems in imaging studies. © 1993 wiley‐Liss, Inc.

[1]  R. Roth,et al.  Cocaine-sensitive and -insensitive dopamine uptake in prefrontal cortex, nucleus accumbens and striatum , 1993, Neurochemistry International.

[2]  P. Jatlow,et al.  Cocaine and Cocaethylene: Microdialysis Comparison of Brain Drug Levels and Effects on Dopamine and Serotonin , 1993, Journal of neurochemistry.

[3]  A. Mcgregor,et al.  L-Tryptophan decreases the breaking point under a progressive ratio schedule of intravenous cocaine reinforcement in the rat , 1993, Pharmacology Biochemistry and Behavior.

[4]  P. Kalivas,et al.  Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  P Duffy,et al.  Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  A. Kozikowski,et al.  Structure-activity relationship studies of cocaine: replacement of the C-2 ester group by vinyl argues against H-bonding and provides an esterase-resistant, high-affinity cocaine analogue. , 1992, Journal of medicinal chemistry.

[7]  M. Kuhar,et al.  Selective dopamine transporter inhibition by cocaine analogs. , 1992, Neuroreport.

[8]  B. Penke,et al.  The cocaine-induced elevation of plasma corticosterone is mediated by endogenous corticotropin-releasing factor (CRF) in rats , 1992, Brain Research.

[9]  P. Piazza,et al.  Repeated corticosterone administration sensitizes the locomotor response to amphetamine , 1992, Brain Research.

[10]  K. Cunningham,et al.  Chronic cocaine enhances serotonin autoregulation and serotonin uptake binding , 1992, Synapse.

[11]  F. J. White,et al.  Electrophysiological Correlates of Psychomotor Stimulant‐induced Sensitization a , 1992, Annals of the New York Academy of Sciences.

[12]  L. D. van de Kar,et al.  Cocaine-induced elevation of plasma adrenocorticotropin hormone and corticosterone is mediated by serotonergic neurons. , 1991, The Journal of pharmacology and experimental therapeutics.

[13]  N. Greig,et al.  GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine , 1991, Pharmacology Biochemistry and Behavior.

[14]  P. Kalivas,et al.  Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity , 1991, Brain Research Reviews.

[15]  S. Yi,et al.  Effect of cocaine and 5-HT3 receptor antagonists on 5-HT-induced [3H]dopamine release from rat striatal synaptosomes. , 1991, European journal of pharmacology.

[16]  D. Mash,et al.  Cocaethylene: A Unique Cocaine Metabolite Displays High Affinity for the Dopamine Transporter , 1991, Journal of neurochemistry.

[17]  L. Chiodo,et al.  Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. , 1990, The Journal of pharmacology and experimental therapeutics.

[18]  J. B. Justice,et al.  In vivo microdialysis and thermospray tandem mass spectrometry of the dopamine uptake blocker 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)-piper azine (GBR-12909). , 1990, Analytical chemistry.

[19]  M. Carroll,et al.  Fluoxetine reduces intravenous cocaine self-administration in rats , 1990, Pharmacology Biochemistry and Behavior.

[20]  J. Green,et al.  Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. , 1989, The Journal of pharmacology and experimental therapeutics.

[21]  W. Mcbride,et al.  Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release , 1989, Brain Research Bulletin.

[22]  R. Post,et al.  Context-Dependent Cocaine Sensitization: Differential Effect of Haloperidol on Development Versus Expression , 1989, Pharmacology Biochemistry and Behavior.

[23]  R. Spealman,et al.  Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.

[24]  L. Stinus,et al.  Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation , 1989, Brain Research.

[25]  A. Kelley,et al.  Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat. , 1989, European journal of pharmacology.

[26]  M. Kuhar,et al.  Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. , 1989, The Journal of pharmacology and experimental therapeutics.

[27]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[28]  P. Kalivas,et al.  Sensitization in the Nervous System , 1988 .

[29]  R. Vertes,et al.  Autoradiographic analysis of ascending projections from the pontine and mesencephalic reticular formation and the median raphe nucleus in the rat , 1988, The Journal of comparative neurology.

[30]  S. Chaki,et al.  5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. , 1988, European journal of pharmacology.

[31]  P. Johansen,et al.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  A. Beaudet,et al.  Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons , 1987, Brain Research.

[33]  M. Rowbotham,et al.  Acute neurologic and psychiatric complications associated with cocaine abuse. , 1987, The American journal of medicine.

[34]  W. Vale,et al.  Cocaine stimulates adrenocorticotropin (ACTH) secretion through a corticotropin-releasing factor (CRF)-mediated mechanism , 1987, Brain Research.

[35]  A. Fischman,et al.  Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone , 1987, Peptides.

[36]  E. Uhlenhuth,et al.  Reinforcing and subjective effects of several anorectics in normal human volunteers. , 1987, The Journal of pharmacology and experimental therapeutics.

[37]  D. Pitts,et al.  Cocaine modulation of central monoaminergic neurotransmission , 1987, Pharmacology Biochemistry and Behavior.

[38]  E. Uhlenhuth,et al.  The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans , 1986, Pharmacology Biochemistry and Behavior.

[39]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[40]  N. Goeders,et al.  Cortical dopaminergic involvement in cocaine reinforcement. , 1983, Science.

[41]  T. Westfall,et al.  Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices , 1982, Neuroscience Letters.

[42]  P. Somogyi,et al.  Neurotransmitter-specific projection neurons revealed by combining PAP immunohistochemistry with retrograde transport of HRP , 1981, Brain Research.

[43]  B. Cox,et al.  Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum , 1981, Journal of neurochemistry.

[44]  P. V. D. Zee,et al.  ARYL 1,4-DIALK(EN)YLPIPERAZINES AS SELECTIVE AND VERY POTENT INHIBITORS OF DOPAMINE UPTAKE , 1981 .

[45]  H. Bradford,et al.  Presynaptic Control of the Synthesis and Release of Dopamine from Striatal Synaptosomes: A Comparison Between the Effects of 5‐Hydroxytryptamine, Acetylcholine, and Glutamate , 1980, Journal of neurochemistry.

[46]  J. Glowinski,et al.  Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat , 1979, Neuroscience Letters.

[47]  R. Moore,et al.  Serotonin neurons of the midbrain raphe: Ascending projections , 1978, The Journal of comparative neurology.

[48]  H. Fibiger,et al.  An anatomical and electrophysiological investigation of the serotonergic projection from the dorsal raphe nucleus to the substantia nigra in the rat , 1977, Neuroscience.

[49]  H. Fibiger,et al.  On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine , 1977, Pharmacology Biochemistry and Behavior.

[50]  S. Iversen,et al.  Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats , 1976 .

[51]  C. Marsden,et al.  Serotoninergic modulation of the dopamine response from the nucleus accumbens , 1976, The Journal of pharmacy and pharmacology.

[52]  T. Chase,et al.  Release of [3H]dopamine byl-5-hydroxytryptophan , 1972 .

[53]  O. Hornykiewicz,et al.  A model for the quantitative study of central dopaminergic and serotoninergic activity. , 1972, European journal of pharmacology.

[54]  J. Witkin,et al.  Comparative behavioral pharmacology and toxicology of cocaine and its ethanol-derived metabolite, cocaine ethyl-ester (cocaethylene). , 1992, Life sciences.

[55]  M. Kuhar,et al.  2 beta-substituted analogues of cocaine. Synthesis and inhibition of binding to the cocaine receptor. , 1992, Journal of medicinal chemistry.

[56]  B. Penke,et al.  Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats. , 1992, Life sciences.

[57]  N. R. Richardson,et al.  Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat. , 1991, Life sciences.

[58]  R. Roth,et al.  Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. , 1991, Life sciences.

[59]  M. Le Moal,et al.  Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. , 1990, Life sciences.

[60]  J. Lakoski,et al.  The interaction of cocaine with serotonin dorsal raphe neurons. Single-unit extracellular recording studies. , 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[61]  M. Kuhar,et al.  Synthesis and receptor binding of cocaine analogs. , 1990, NIDA research monograph.

[62]  R. Roth,et al.  Cocaethylene inhibits uptake of dopamine and can reach high plasma concentrations following combined cocaine and ethanol use. , 1990, NIDA research monograph.

[63]  L. Porrino,et al.  Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. , 1989, Life sciences.

[64]  M. A. Klein,et al.  Cocaine abuse: neurovascular complications. , 1989, Radiology.

[65]  R. Corwin,et al.  Anorectics: effects on food intake and self-administration in rhesus monkeys. , 1987, Alcohol and drug research.

[66]  D. van der Kooy,et al.  The nucleus raphe dorsalis of the rat and its projection upon the caudatoputamen. A combined cytoarchitectonic, immunohistochemical and retrograde transport study. , 1981, Journal de physiologie.

[67]  S. Pradhan,et al.  Serotoninergic manipulation of the behavioral effects of cocaine in rats. , 1978, Communications in psychopharmacology.

[68]  J. Scheel-Krüger,et al.  Cocaine: Discussion on the Role of Dopamine in the Biochemical Mechanism of Action , 1977 .

[69]  T. Chase,et al.  Release of ( 3 H)dopamine by L-5-hydroxytryptophan. , 1972, Brain research.